被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| Australia: Safety advisory: Li Da Daidaihua capsules contain the undeclared substance sibutramine (English only) |
| |
Therapeutic Goods Administration (TGA) announces that Li Da Daidaihua capsules pose a serious risk to health and should not be taken. TGA has tested a product labelled Li Da Daidaihua capsules and found that the capsules contain the undeclared substance sibutramine.
Consumers are advised that sibutramine is a prescription-only substance in Australia. Sibutramine was withdrawn from world markets in 2010 due to increased risk of cardiac events and stroke. The supply of Li Da Daidaihua capsules containing undisclosed sibutramine is illegal. Li Da Daidaihua capsules have not been assessed by TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by TGA.
Consumers should stop using Li Da Daidaihua capsules and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their health care practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/news/safety-alerts/li-da-daidaihua-capsules-safety-advisory
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Tuesday, Dec 12, 2023
Issued at HKT 15:00
|
| |
